Prevention of transfusion-associated cytomegalovirus infection - Practice parameter

被引:0
|
作者
Przepiorka, D
LeParc, GF
Werch, J
Lichtiger, B
机构
[1] UNIV TEXAS, MD ANDERSON CANC CTR, DEPT LAB MED, HOUSTON, TX USA
[2] UNIV S FLORIDA, DEPT LAB MED, TAMPA, FL USA
[3] BAYLOR COLL MED, DEPT PATHOL, HOUSTON, TX 77030 USA
关键词
cytomegalovirus infection; transfusion-associated infection; blood filtration; screen blood components;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
This practice guideline represents the opinions and recommendations of the author(s), the American Society of Clinical Pathologists (ASCP) Practice Parameters Committee and the ASCP Board of Directors regarding the appropriate strategies for each clinical condition or laboratory test discussed in this guideline. This guideline is designed primarily as an educational resource for physicians in the provision of quality medical services. Adherence to this guideline is completely voluntary and does not necessarily assure a successful medical treatment or result. This practice guideline should not he considered inclusive of all proper procedures and tests or exclusive of other procedures or tests that are reasonably directed to obtaining the same results. The physician should apply his or her own professional judgment to the unique clinical circumstances presented by the particular procedure or test. Physicians are encouraged to document the reasons for whatever procedure or test they use (whether or not in conformance with this guideline). Physicians should also take care to consider other medical and scientific advances that are available after the date of adoption of this guideline. This practice guideline was developed exclusively for the purposes set forth above and not for use in connection with matters involving reimbursement, credentialing, or utilization review.
引用
收藏
页码:163 / 169
页数:7
相关论文
共 50 条
  • [41] Possible mechanisms of allogeneic blood transfusion-associated postoperative infection
    Vamvakas, EC
    TRANSFUSION MEDICINE REVIEWS, 2002, 16 (02) : 144 - 160
  • [42] TRANSFUSION-ASSOCIATED HIV INFECTION - REPORT OF 38 PEDIATRIC CASES
    KONE, I
    MICHEL, G
    THURET, I
    SICCARDI, F
    VALLEE, D
    JUHAN, I
    PERRIMOND, H
    ARCHIVES FRANCAISES DE PEDIATRIE, 1989, 46 (07): : 499 - 502
  • [43] Transfusion-associated graft-versus-host disease with transfusion practice in cardiac surgery
    Yasuura, K
    Okamoto, H
    Matsuura, A
    JOURNAL OF CARDIOVASCULAR SURGERY, 2000, 41 (03): : 377 - 380
  • [44] Transfusion-associated graft-versus-host disease and its prevention
    Williamson, LM
    Warwick, RM
    BLOOD REVIEWS, 1995, 9 (04) : 251 - 261
  • [45] IRRADIATION IN THE PREVENTION OF TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE
    WEBB, DKH
    ARCHIVES OF DISEASE IN CHILDHOOD, 1995, 73 (05) : 388 - 389
  • [46] Developments in the prevention of transfusion-associated graft-versus-host disease
    Fast, Loren D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 158 (05) : 563 - 568
  • [47] VARIATION IN BLOOD COMPONENT IRRADIATION PRACTICE - IMPLICATIONS FOR PREVENTION OF TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE
    ANDERSON, KC
    GOODNOUGH, LT
    SAYERS, M
    PISCIOTTO, PT
    KURTZ, SR
    LANE, TA
    ANDERSON, CS
    SILBERSTEIN, LE
    BLOOD, 1991, 77 (10) : 2096 - 2102
  • [48] TRANSFUSION-ASSOCIATED VIRAL HEPATITIS
    MOSLEY, JW
    DULL, HB
    ANESTHESIOLOGY, 1966, 27 (04) : 409 - &
  • [49] Transfusion-Associated Circulatory Overload and Transfusion-Related Acute Lung Injury: Etiology and Prevention
    Roubinian, Nareg H.
    Triulzi, Darrell J.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2019, 33 (05) : 767 - +
  • [50] REPORTING TRANSFUSION-ASSOCIATED HEPATITIS
    GRINDON, AJ
    ROSVOLL, RV
    TRANSFUSION, 1980, 20 (01) : 108 - 109